Turning the TIDE: oligonucleotide development trends
Discover what is driving the oligonucleotide therapeutics sector as scientists navigate challenges such as financing and success-to-market.
Stay updated with breaking news from Dave Madge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover what is driving the oligonucleotide therapeutics sector as scientists navigate challenges such as financing and success-to-market.
Peptide technology company Orbit Discovery has announced a partnership with WuXi AppTec that will see the combination of its peptide discovery platform and experience with the Chinese organisation’s downstream capabilities as a leading global provider of R&D and manufacturing services provision for the pharmaceutical and healthcare industry. Click to read more...
WuXi AppTec’s development and manufacturing platform will enable Orbit to generate peptides at small or large scale